| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028178758 |
| P356 | DOI | 10.2165/11597960-000000000-00000 |
| P698 | PubMed publication ID | 22191792 |
| P50 | author | Constance Schultsz | Q28595124 |
| P2093 | author name string | Suzanne Geerlings | |
| P2860 | cites work | Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study | Q24617818 |
| Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan | Q24633186 | ||
| Updated functional classification of beta-lactamases | Q24644798 | ||
| Plasmid-mediated quinolone resistance: a multifaceted threat | Q24645356 | ||
| Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India | Q24647709 | ||
| Carbapenemases: the versatile beta-lactamases | Q24685034 | ||
| Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. | Q54364029 | ||
| Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. | Q54373146 | ||
| Identification of NDM-1-producing Enterobacteriaceae in Norway. | Q54373776 | ||
| Global spread of New Delhi metallo-β-lactamase 1. | Q54375095 | ||
| Global spread of New Delhi metallo-β-lactamase 1. | Q54400269 | ||
| Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality. | Q54427482 | ||
| First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. | Q54438035 | ||
| Distribution of conjugative-plasmid-mediated 16S rRNA methylase genes among amikacin-resistant Enterobacteriaceae isolates collected in 1995 to 1998 and 2001 to 2006 at a university hospital in South Korea and identification of conjugative plasmids m | Q57215473 | ||
| Global spread of New Delhi metallo-β-lactamase 1 | Q57858255 | ||
| Global spread of New Delhi metallo-β-lactamase 1 | Q57935652 | ||
| Comment on: Redefining extended-spectrum -lactamases: balancing science and clinical need | Q58089062 | ||
| New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe | Q59239391 | ||
| Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1 | Q59275417 | ||
| Cefotaxime resistance and outcome of Klebsiella spp bloodstream infection | Q61767059 | ||
| European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe | Q61776342 | ||
| Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations o | Q62635883 | ||
| Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women | Q72750914 | ||
| Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel | Q82993162 | ||
| Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland | Q83069776 | ||
| Tigecycline: benefits and risks | Q84588799 | ||
| Antibiotics for emerging pathogens | Q29615377 | ||
| The CTX-M beta-lactamase pandemic. | Q30356558 | ||
| Extended-spectrum beta-lactamases and clinical outcomes: current data | Q33236875 | ||
| Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones | Q33301096 | ||
| Presence of qnr gene in Escherichia coli and Klebsiella pneumoniae resistant to ciprofloxacin isolated from pediatric patients in China | Q33337220 | ||
| High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital | Q33614251 | ||
| Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease | Q33776590 | ||
| A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance | Q33883793 | ||
| Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. | Q34096605 | ||
| Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection | Q34109281 | ||
| IncI1 plasmid carrying extended-spectrum-beta-lactamase gene blaCTX-M-1 in Salmonella enterica isolates from poultry and humans in France, 2003 to 2008. | Q34151202 | ||
| Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. | Q34177006 | ||
| National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases | Q34309458 | ||
| Aminoglycoside modifying enzymes | Q34354185 | ||
| Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center | Q34370760 | ||
| Emergence of Klebsiella pneumoniae coproducing KPC-2 and 16S rRNA methylase ArmA in Poland | Q34483498 | ||
| Detection of NDM-1-producing Klebsiella pneumoniae in Kenya | Q34529033 | ||
| The worldwide emergence of plasmid-mediated quinolone resistance | Q34569740 | ||
| Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides | Q34689108 | ||
| Fosfomycin: use beyond urinary tract and gastrointestinal infections | Q34774778 | ||
| Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies | Q34803735 | ||
| The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria | Q34969565 | ||
| Multidrug-resistant Gram-negative infections: what are the treatment options? | Q35002302 | ||
| Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase | Q35019811 | ||
| Fluoroquinolones: structure and target sites | Q35056637 | ||
| Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients | Q35065863 | ||
| New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada | Q35482908 | ||
| New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate | Q36094929 | ||
| Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections | Q36095874 | ||
| Mechanisms of resistance to quinolones | Q36155441 | ||
| Community-associated meticillin-resistant Staphylococcus aureus | Q36438720 | ||
| A step closer to extreme drug resistance (XDR) in gram-negative bacilli | Q43876962 | ||
| Balkan NDM-1: escape or transplant? | Q43967079 | ||
| Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. | Q44099225 | ||
| Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? | Q44243558 | ||
| ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China | Q44285126 | ||
| First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan | Q44424048 | ||
| Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York | Q44904821 | ||
| Clinical efficacy of temocillin. | Q45972234 | ||
| Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections. | Q45981762 | ||
| Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden | Q46121462 | ||
| Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? | Q46634720 | ||
| Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-beta-lactamase VIM-2 in a hematology unit of a French hospital | Q46733423 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. | Q51046510 | ||
| Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. | Q53216475 | ||
| Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes | Q36538655 | ||
| Defining an extended-spectrum beta-lactamase | Q37043580 | ||
| Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints | Q37043635 | ||
| Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern | Q37091253 | ||
| Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections | Q37190732 | ||
| Resistance plasmid families in Enterobacteriaceae | Q37204254 | ||
| Detection of plasmid-mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intrahospital transmission | Q37214062 | ||
| oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae | Q37274700 | ||
| Redefining extended-spectrum beta-lactamases: balancing science and clinical need | Q37291469 | ||
| Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection | Q37392904 | ||
| Diversity, epidemiology, and genetics of class D beta-lactamases | Q37590023 | ||
| Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections | Q37614630 | ||
| Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae | Q37769667 | ||
| Integrons. | Q37779789 | ||
| Plasmid-mediated quinolone resistance: an update. | Q37795644 | ||
| Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae | Q37797732 | ||
| How to detect NDM-1 producers | Q37814754 | ||
| Metallo-β-lactamases: a last frontier for β-lactams? | Q37870462 | ||
| Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis | Q37904495 | ||
| Spread of OXA-48-encoding plasmid in Turkey and beyond | Q38933125 | ||
| Differential phenotypic and genotypic characteristics of qnrS1-harboring plasmids carried by hospital and community commensal enterobacteria | Q39560238 | ||
| Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China | Q41761721 | ||
| Carbapenem Heteroresistance in VIM-1-Producing Klebsiella pneumoniae Isolates Belonging to the Same Clone: Consequences for Routine Susceptibility Testing | Q41837190 | ||
| Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. | Q41927897 | ||
| Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia | Q42012070 | ||
| Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. | Q42111230 | ||
| Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. | Q42112165 | ||
| Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs | Q42355473 | ||
| Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. | Q42577452 | ||
| Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials | Q42643577 | ||
| NDM-1-producing Escherichia coli in Germany | Q42706276 | ||
| In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC. | Q42706278 | ||
| International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France | Q42706377 | ||
| Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France | Q42727162 | ||
| Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo- -lactamase | Q42874712 | ||
| Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. | Q42945869 | ||
| Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides | Q42976467 | ||
| Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli. | Q43121836 | ||
| Effectiveness and safety of colistin: prospective comparative cohort study | Q43124623 | ||
| An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes | Q43204996 | ||
| Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin | Q43207954 | ||
| Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients | Q43223792 | ||
| Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010. | Q43470080 | ||
| NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman | Q43507490 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Enterobacteriaceae | Q380136 |
| P304 | page(s) | 1-16 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy | |
| P478 | volume | 72 |
| Q91723200 | A ParDE-family toxin antitoxin system in major resistance plasmids of Enterobacteriaceae confers antibiotic and heat tolerance |
| Q50503492 | Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone. |
| Q39528561 | An insight into future antibacterial therapy |
| Q91788081 | An overview of the antimicrobial resistance mechanisms of bacteria |
| Q28481714 | Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China |
| Q40622938 | Antimicrobial-resistant Escherichia coli in hospitalised companion animals and their hospital environment |
| Q26739860 | Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). |
| Q34058006 | Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents. |
| Q38068483 | Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back? |
| Q30361739 | Characteristics of surgical patients receiving inappropriate empiric antimicrobial therapy. |
| Q40735141 | Comparative effects of overproducing the AraC-type transcriptional regulators MarA, SoxS, RarA and RamA on antimicrobial drug susceptibility in Klebsiella pneumoniae |
| Q87690887 | Conjugative ESBL plasmids differ in their potential to rescue susceptible bacteria via horizontal gene transfer in lethal antibiotic concentrations |
| Q44513436 | Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin |
| Q38088261 | Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections |
| Q47656787 | Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired β-lactam resistance. |
| Q37036459 | Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center. |
| Q27015697 | Escherichia coli in Europe: an overview |
| Q38063968 | Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment |
| Q34702903 | Frequency and factors associated with carriage of multi-drug resistant commensal Escherichia coli among women attending antenatal clinics in central India |
| Q34580610 | Genome Sequence of a Multidrug-Resistant Strain of Klebsiella pneumoniae, BAMC 07-18, Isolated from a Combat Injury Wound |
| Q38878917 | Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study |
| Q45223510 | In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014. |
| Q37203872 | In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B. |
| Q36051105 | Local transmission and global dissemination of New Delhi Metallo-Beta-Lactamase (NDM): a whole genome analysis. |
| Q40552898 | Low biological cost of carbapenemase-encoding plasmids following transfer from Klebsiella pneumoniae to Escherichia coli |
| Q37694277 | Mortality associated with community-acquired cephalosporin-resistant Escherichia coli in patients admitted to a district hospital in a resource-limited setting. |
| Q35104348 | Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm |
| Q28538578 | Plasmid-mediated sulfamethoxazole resistance encoded by the sul2 gene in the multidrug-resistant Shigella flexneri 2a isolated from patients with acute diarrhea in Dhaka, Bangladesh |
| Q55439787 | Prevalence of extended spectrum beta lactamase and plasmid mediated quinolone resistant genes in strains of Klebsiella pneumonia, Morganella morganii, Leclercia adecarboxylata and Citrobacter freundii isolated from poultry in South Western Nigeria. |
| Q38151574 | Selective decontamination of the digestive tract in gastrointestinal surgery: useful in infection prevention? A systematic review |
| Q64109227 | Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli |
| Q38805792 | Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains. |
| Q42277917 | TG13 antimicrobial therapy for acute cholangitis and cholecystitis |
| Q59052497 | The Occurrence ofblaCTX-M,blaSHV, andblaTEMGenes in Extended-Spectrumβ-Lactamase-Positive Strains ofKlebsiella pneumoniae,Escherichia coli, andProteus mirabilisin Poland |
| Q97085645 | The environmental contribution to the dissemination of carbapenem and (fluoro)quinolone resistance genes by discharged and reused wastewater effluents: The role of cellular and extracellular DNA |
| Q38031315 | The microbiome of the chicken gastrointestinal tract. |
| Q46770277 | Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. |
| Q64229824 | Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals |
Search more.